Brief: BioArctic Q1 Operating Profit SEK -73.1 Million
17/05/2024 07:00
May 17 (Reuters) - BioArctic Q1 adjusted free cash flow SEK -114.4 million. * Q1 net income SEK -57.6 million * Q1 adjusted EPS SEK -0.65
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln